Northrop Grumman Corporation
NOC
$532.23
-2.36%
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems, including autonomous aircraft, the B-21 bomber, F-35 fuselage, missile systems, and advanced sensors. As a top-tier prime contractor in the aerospace and defense industry, it holds a distinct competitive position through its involvement in high-priority programs like the B-21 and F-35. The current investor narrative centers on geopolitical tailwinds from U.S.-Iran tensions and the Pentagon's AI pivot, which are driving attention to defense stocks, though recent price weakness has sparked debate about valuation support and near-term momentum.…
NOC
Northrop Grumman Corporation
$532.23
Related headlines
Investment Opinion: Should I buy NOC Today?
Rating: Hold. NOC is a fundamentally sound defense contractor with a discounted valuation, but persistent price weakness and negative momentum warrant caution. The analyst consensus is bullish with an average target of ~$672, implying 22% upside, but the stock's recent underperformance suggests risks are not fully priced in. Supporting evidence includes: trailing PE of 19.57x (11% discount to sector), revenue growth of 9.6% YoY, net margin of 12.2%, and TTM free cash flow of $3.31B. However, the negative beta (-0.10) and 3-month relative strength of -35.4% indicate strong selling pressure. Risks that could invalidate the thesis include: a defense budget cut, program cancellations, or a broader market downturn that further compresses multiples. This Hold would upgrade to Buy if the stock breaks above its 200-day moving average or if forward PE compresses below 16x, and downgrade to Sell if revenue growth decelerates below 5% or debt-to-equity rises above 1.5. Overall, NOC appears fairly valued relative to its history but undervalued relative to peers, though the market's skepticism may persist.
Sign up to view all
NOC 12-Month Price Forecast
NOC presents a classic value trap risk: strong fundamentals but persistent price weakness. The 11% PE discount to peers is attractive, but the negative momentum and idiosyncratic risks (negative beta) suggest the market is pricing in concerns beyond valuation. The base case of gradual recovery to $580-650 is most likely, supported by stable defense spending. However, the bear case of a drop to $490 cannot be ignored given the stock's recent trajectory. Upgrade to bullish if the stock breaks above $600 with volume; downgrade to bearish if it breaks below $500.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Northrop Grumman Corporation's 12-month outlook, with a consensus price target around $691.90 and implied upside of +30.0% versus the current price.
Average Target
$691.90
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$426 - $692
Analyst target range
The stock is covered by 8 analysts, with a consensus leaning bullish: ratings include Buy from BTIG, UBS, Citigroup, and B of A Securities, and Outperform from RBC Capital, while Jefferies and Truist Securities rate it Hold. The average target price is not explicitly provided, but based on the estimated EPS of $36.95 and forward PE of 18.20x, the implied target is approximately $672. This suggests about 22% upside from the current price of $549.01. The consensus is bullish, supported by recent upgrades and positive geopolitical catalysts. The target range is not explicitly given, but the high EPS estimate of $37.71 and low of $36.35 imply a narrow spread, indicating relatively high conviction among analysts. The high target likely assumes continued defense spending growth and successful program execution, while the low target may factor in potential budget cuts or supply chain disruptions. Recent ratings actions show mostly reaffirmations of Buy/Outperform, with one downgrade from Truist Securities to Hold in January 2026, suggesting some caution but overall positive sentiment.
Bulls vs Bears: NOC Investment Factors
Northrop Grumman presents a mixed picture: strong fundamentals with accelerating revenue, solid profitability, and a discounted valuation are countered by severe price underperformance, high debt, and dependence on government spending. The bull case is supported by geopolitical catalysts and analyst optimism, while the bear case highlights persistent selling pressure and idiosyncratic risks. The single most important tension is whether the recent price weakness is a buying opportunity or a signal of deeper issues—resolution will likely come from upcoming earnings and defense budget clarity.
Bullish
- Geopolitical Tailwinds from Iran Tensions: Recent U.S.-Iran retaliatory strikes and heightened geopolitical risks are direct catalysts for defense spending, benefiting NOC's core programs like the B-21 bomber and missile systems. This has already triggered a rally in defense stocks, as noted in June 2026 news.
- Strong Revenue Growth Acceleration: Q4 2025 revenue grew 9.6% YoY to $11.71B, with TTM revenue accelerating from $9.47B in Q1 2025 to $11.71B in Q4 2025, driven by Aeronautics Systems ($3.92B) and Mission Systems ($3.45B). This consistent growth supports the investment thesis.
- Attractive Valuation Discount to Peers: NOC's trailing PE of 19.57x is an 11% discount to the sector average of 22.0x, and its forward PE of 18.20x implies modest earnings growth. This discount may be unjustified given the company's solid profitability and defense program backlog.
- Healthy Free Cash Flow Generation: Q4 2025 free cash flow was $3.24B, bringing TTM FCF to $3.31B, with a payout ratio of 30.9%. This strong cash generation supports dividends (yield 1.58%) and provides flexibility for investments or share buybacks.
Bearish
- Severe Underperformance vs. Market: NOC's 1-year return of +10.0% significantly lags the S&P 500's +19.1%, and the 3-month relative strength is -35.4%, indicating persistent selling pressure. The stock is trading at 71% of its 52-week range, near the low end.
- High Debt-to-Equity Ratio: Debt-to-equity of 1.18 is elevated, and interest expense of $175M in Q4 2025 represents a fixed cost that could pressure earnings if revenues decline. The current ratio of 1.09 suggests only adequate liquidity.
- Dependence on Government Contracts: NOC's revenue is heavily tied to U.S. defense budgets, which are subject to political uncertainty and potential future cuts. Any slowdown in defense spending growth could directly impact revenue and margins.
- Negative Beta and Idiosyncratic Risk: With a beta of -0.10, NOC moves inversely to the market, which is unusual for a defense stock. This suggests company-specific factors are driving performance, and the stock may not benefit from broad market rallies.
NOC Technical Analysis
The stock is in a sustained downtrend over the past year, with a 1-year price change of +10.0% significantly underperforming the S&P 500's +19.1%. The current price of $549.01 sits at 71% of its 52-week range (low $493.84, high $774.00), indicating it is closer to the low end, which could suggest a value opportunity but also reflects persistent selling pressure. Short-term momentum is mixed: the 1-month change is +2.3% while the 3-month change is -21.8%, showing a sharp recent decline that has partially recovered. The 1-month relative strength of +3.6% versus the S&P 500 suggests a slight bounce, but the 3-month relative strength of -35.4% confirms severe underperformance. This divergence between the short-term bounce and longer-term weakness could signal a temporary pullback rather than a trend reversal. The 52-week low of $493.84 provides key support, while the 52-week high of $774.00 is the resistance level. A breakout above $774 would signal a major reversal, while a breakdown below $493.84 could accelerate losses. The beta of -0.10 indicates the stock has historically moved inversely to the market, which is unusual for a defense stock and may reflect idiosyncratic factors; this low beta suggests lower systematic risk but does not eliminate company-specific volatility.
Beta
-0.10
-0.10x market volatility
Max Drawdown
-35.4%
Largest decline past year
52-Week Range
$494-$774
Price range past year
Annual Return
+4.8%
Cumulative gain past year
| Period | NOC Return | S&P 500 |
|---|---|---|
| 1m | -3.0% | +2.0% |
| 3m | -21.0% | +10.6% |
| 6m | -14.0% | +8.3% |
| 1y | +4.8% | +20.4% |
| ytd | -9.1% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOC Fundamental Analysis
Revenue has been growing, with Q4 2025 revenue of $11.71 billion up 9.6% year-over-year from $10.69 billion in Q4 2024. The trailing twelve-month revenue trend shows acceleration from $9.47 billion in Q1 2025 to $11.71 billion in Q4 2025, driven by strong performance in Aeronautics Systems ($3.92B) and Mission Systems ($3.45B). This growth trajectory supports the investment case as defense spending remains elevated. Profitability is solid: net income for Q4 2025 was $1.43 billion, with a gross margin of 19.6% and an operating margin of 8.9%. Net margin improved to 12.2% in Q4 2025 from 11.8% in Q4 2024, indicating stable profitability. The company is consistently profitable with EPS of $9.99 in Q4 2025, up from $8.66 a year earlier. The balance sheet is healthy: debt-to-equity is 1.18, and free cash flow for Q4 2025 was $3.24 billion, bringing TTM FCF to $3.31 billion. The current ratio of 1.09 suggests adequate liquidity, and ROE of 25.1% reflects strong returns on equity. The company generates sufficient cash to fund operations and dividends, with a payout ratio of 30.9%.
Quarterly Revenue
$11.7B
2025-12
Revenue YoY Growth
+9.60%
YoY Comparison
Gross Margin
19.60%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOC Overvalued?
Since net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 19.57x, while the forward PE is 18.20x, implying the market expects earnings growth. The gap between trailing and forward PE suggests modest growth expectations. Compared to the industry, the stock trades at a PE of 19.57x versus the sector average of 22.0x (estimated), a discount of about 11%. This discount may be justified by the stock's recent underperformance and lower growth expectations relative to peers. Historically, the trailing PE of 19.57x is near the middle of its 5-year range (roughly 10x to 40x), indicating it is not at extreme levels. The current PE is below the Q4 2025 historical PE of 14.28x, suggesting the stock has become cheaper relative to earnings. This could represent a value opportunity if fundamentals remain strong, but the discount also reflects market skepticism about future growth.
PE
19.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: NOC's debt-to-equity of 1.18 is elevated, and interest expense of $175M in Q4 2025 represents a fixed cost that could pressure earnings if revenues decline. The current ratio of 1.09 suggests only adequate liquidity, and while free cash flow is strong at $3.31B TTM, any disruption in contract payments could strain operations. Revenue concentration in government contracts (over 90%) means a single budget cut could significantly impact top-line growth. Market & Competitive Risks: The stock's negative beta of -0.10 indicates it does not participate in market rallies, and its 3-month relative strength of -35.4% shows severe underperformance. Valuation compression is a risk if the PE discount to peers (19.57x vs 22.0x) widens further due to market skepticism. Competitive threats from other primes like Lockheed Martin and emerging AI-focused defense contractors could erode NOC's market share. Geopolitical tensions are a double-edged sword—while they boost defense spending, they also introduce uncertainty. Worst-Case Scenario: A combination of defense budget cuts, program delays (e.g., B-21), and margin compression could drive the stock to its 52-week low of $493.84, representing a 10% decline from the current price of $549.01. In a severe recession or geopolitical de-escalation, the stock could fall further to $450, a 18% loss, based on historical max drawdown of -35.42% from the 52-week high of $774.00.
FAQ
The key risks are: 1) Financial risk: high debt-to-equity of 1.18 and interest expense of $175M per quarter could pressure earnings if revenues decline. 2) Market risk: the stock's negative beta (-0.10) means it may not benefit from market rallies, and its 3-month relative strength of -35.4% indicates severe underperformance. 3) Regulatory risk: dependence on U.S. defense budgets makes NOC vulnerable to political changes or budget cuts. 4) Company-specific risk: program delays (e.g., B-21) or supply chain disruptions (rare earths) could impact revenue and margins. The most severe risk is a defense budget sequestration that could drive the stock to $493.84 or lower.
The 12-month outlook is mixed: the bull case (30% probability) sees the stock reaching $650-720 driven by geopolitical escalation and program acceleration. The base case (45% probability) targets $580-650 with stable defense spending and gradual recovery. The bear case (25% probability) sees the stock falling to $490-550 due to budget cuts or program issues. The most likely scenario is the base case, assuming no major changes in defense spending. Analyst consensus is bullish with an average target of ~$672, implying 22% upside from the current price of $549.01.
NOC appears undervalued relative to its industry peers, with a trailing PE of 19.57x versus the sector average of 22.0x, an 11% discount. Historically, the PE is near the middle of its 5-year range (10x-40x), suggesting it is not at extreme levels. The forward PE of 18.20x implies modest earnings growth expectations. The market is pricing in skepticism about future growth, possibly due to recent underperformance and high debt levels. Given NOC's solid profitability (net margin 12.2%) and strong free cash flow ($3.31B TTM), the current valuation offers a margin of safety for value-oriented investors.
NOC offers a compelling risk/reward for patient investors: the stock trades at a trailing PE of 19.57x, an 11% discount to the sector average of 22.0x, with analyst targets implying 22% upside to ~$672. However, the stock has severely underperformed the market (1-year return +10.0% vs S&P +19.1%) and has a negative beta of -0.10, indicating idiosyncratic risk. The biggest downside risk is a defense budget cut that could drive the stock to its 52-week low of $493.84. For long-term investors with a 3-5 year horizon, NOC is a good buy at current levels given its strong fundamentals and discounted valuation. Short-term traders should wait for a confirmed breakout above $600.
NOC is better suited for long-term investment due to its stable defense contracts, consistent profitability, and dividend yield of 1.58%. The stock's beta of -0.10 indicates low correlation with the market, making it a potential portfolio diversifier. However, its recent price weakness and negative momentum make it less suitable for short-term trading. A minimum holding period of 3-5 years is recommended to allow the valuation discount to close and for defense spending trends to play out. Short-term traders should wait for a clear breakout above $600 before entering.